Hydroxyzine Pamoate Capsule
Product Images NDC 51655-252

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydroxyzine Pamoate (NDC 51655-252). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 252 52 Rev A 04 23)

Label for Hydroxyzine Pamoate Capsules, USP 50 mg, packaged in a container of 30 capsules. The label includes the NDC 51655-252-52, storage instructions at 20°-25°C, and notes that it is Rx only. The product is labeled by Northwind Pharmaceuticals, Indianapolis, IN 46203.*

FDA Label Image

Structural Formula (Image 1)

Chemical structure diagram showing the molecular structure of Hydroxyzine Pamoate, the active ingredient. The image depicts the two chemical components forming the pamoate salt, including a chloro-substituted phenyl ring, piperazine ring, and a complex polycyclic acid moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.